BIO Convention

Alzheimer’s disease is the 6th leading cause of death in the U.S., according to the Centers for Disease Control and Prevention, affecting 11% of the population 65 years and older. Without a treatment or prevention breakthrough, studies estimate there could be as many as 13.5 million Americans living with the disease by 2050 with associated health care costs rising above $1 trillion.

HR-researcher_1Is the patient voice adequately represented in the drug development process?

RX360logo_noTextMaximizing the return on investment in quality innovation was the topic of a BIO International Convention Super Session on Tuesday which explored challenges and opportunities for pharmaceutical companies in improving efficiencies and ensuring patient safety.

Federally-funded research projects that have advanced medical innovation will be on full display at the BIO International Convention Innovation Zone June 23 ’€“ 26 in San Diego.

Image credit: National Institutes of Health

Image credit: National Institutes of Health


From KIYATEC website

Subscribe to RSS - BIO Convention